Literature DB >> 10772680

Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells.

A Corcione1, L Ottonello, G Tortolina, P Facchetti, I Airoldi, R Guglielmino, P Dadati, M Truini, S Sozzani, F Dallegri, V Pistoia.   

Abstract

BACKGROUND: Follicular center lymphoma displays widespread lymph node involvement at diagnosis. The chemoattractants that control the locomotion of follicular center lymphoma B cells have not been established. Stromal cell-derived factor-1 (SDF-1) is a CXC-class chemokine that enhances the migration of normal human B cells and is expressed in peripheral lymphoid tissues. Here we have investigated 1) whether SDF-1 stimulates the in vitro locomotion of follicular center lymphoma B cells and of their presumed normal counterparts (i. e., germinal center B cells) and 2) whether the same cells express SDF-1 transcripts.
METHODS: B cells were purified by immunomagnetic bead manipulation. Messenger RNA was detected by reverse transcription-polymerase chain reaction. Migration was assessed by the filter and collagen invasion assays. All P values were two sided.
RESULTS: Follicular center lymphoma B lymphocytes showed a statistically significant migratory response to 300 ng/mL SDF-1, both in the filter and in the collagen assays (P =.002 for each). Such response was mediated by the SDF-1 receptor, CXCR4. CD40 monoclonal antibody (MAb) and tonsillar germinal center B cells treated with CD40 MAb and recombinant interleukin 4, but not freshly isolated, migrated statistically significantly faster in the presence than in the absence of SDF-1 (P =.002 in both filter and collagen assays). Freshly isolated follicular center lymphoma and germinal center B cells expressed SDF-1 transcripts.
CONCLUSIONS: This study shows that SDF-1 substantially enhances the migration of follicular center lymphoma B cells but not the migration of freshly purified germinal center B cells. This difference may be related to the extended survival of follicular center lymphoma versus germinal center B cells. SDF-1 produced in follicular center lymphoma lymph nodes may play a role in the local dissemination of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772680     DOI: 10.1093/jnci/92.8.628

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  20 in total

Review 1.  Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.

Authors:  Junxi Wu; Jun Li; Nannan Zhang; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-03-23       Impact factor: 17.165

Review 2.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

Review 3.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

4.  Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse.

Authors:  Martin Wartenberg; Peter Vasil; Christian Meyer zum Bueschenfelde; German Ott; Andreas Rosenwald; Falko Fend; Marcus Kremer
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

5.  Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome.

Authors:  Peter J Mc Guire; Charlotte Cunningham-Rundles; Hans Ochs; George A Diaz
Journal:  Clin Immunol       Date:  2010-03-11       Impact factor: 3.969

6.  IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

Authors:  Elisa Ferretti; Emma Di Carlo; Emanuela Ognio; Giulio Fraternali-Orcioni; Anna Corcione; Beatrice Belmonte; Jean Louis Ravetti; Claudio Tripodo; Domenico Ribatti; Vito Pistoia
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

7.  CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.

Authors:  Karen Brajão de Oliveira; Julie Massayo Maeda Oda; Julio Cesar Voltarelli; Thiago Franco Nasser; Mario Augusto Ono; Thiago Cezar Fujita; Tiemi Matsuo; Maria Angelica Ehara Watanabe
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

8.  Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction.

Authors:  Ankur Saxena; Jason E Fish; Michael D White; Sangho Yu; James W P Smyth; Robin M Shaw; J Michael DiMaio; Deepak Srivastava
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

9.  The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.

Authors:  Irma Airoldi; Emma Di Carlo; Barbara Banelli; Lidia Moserle; Claudia Cocco; Annalisa Pezzolo; Carlo Sorrentino; Edoardo Rossi; Massimo Romani; Alberto Amadori; Vito Pistoia
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

10.  CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes.

Authors:  Anna Corcione; Elisa Ferretti; Maria Bertolotto; Franco Fais; Lizzia Raffaghello; Andrea Gregorio; Claudya Tenca; Luciano Ottonello; Claudio Gambini; Glaucia Furtado; Sergio Lira; Vito Pistoia
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.